|
|
|
|
|
|
|
|
|
|
|
|
|
02.03.26 - 22:36
|
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results (Business Wire)
|
|
|
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14th to review first-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team.
Investors and other interested parties can access the webcast/conference call in the following ways:
The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S...
|
|
|
|
|
|
|
|
|
|
|
|
|
25.02.26 - 21:51
|
Portal Innovations Taps Seasoned Executive to Lead Its Newest Powered by Portal Site at the New Jersey Innovation Hub (Business Wire)
|
|
|
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Sangeetha Ramsagar has been selected as the Executive Director of the New Jersey Innovation Hub, Powered by Portal (NJIH) at the HELIX NJ. Ramsagar will lead strategy, operations, and ecosystem development for the 30,000-square-foot life sciences incubator, advancing its mission to accelerate the formation and growth of next-generation startup companies in New Jersey.
Her hiring marks a key milestone as the NJIH builds dedicated leadership to support founders translating scientific discovery into scalable companies.
Ramsagar brings more than 20 years of experience across pharma, biotechnology commercialization, venture strategy, and portfolio development. Most recently, she served as Founder and CEO of Kronos Health, where she advised emerging biotech companies on commercialization planning and portfolio strategy. Prior to that, she held leadership roles at Flagship Pioneering, Johnson & Johnson, Bayer Healthcare, and Quest Diagnostics, where she guided oncology and n...
|
|
|
25.02.26 - 08:36
|
Bayer verklagt Johnson & Johnson – Aktie fällt und fällt (Der Aktionaer)
|
|
|
Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage ist potenziell irreführende Werbung für ein Prostatakrebs-Medikament der Amerikaner, wodurch diese sich ein Vorteil auf dem milliardenschweren Markt verschafft haben könnten....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
